ALDEYRA THERAPEUTICS, INC.
Assets & Liabilities
| Fiscal Year | Total Liabilities | Total Assets | Cash on Hand |
|---|---|---|---|
| FY2012 | — | — | $1.2M |
| FY2013 | $5.6M | $3.7M | $3.3M |
| FY2014 | $2.5M | $8.8M | $8.5M |
| FY2015 | $3.3M | $28.2M | $14.6M |
| FY2016 | $3.5M | $25.2M | $14.6M |
| FY2017 | $4.6M | $44.2M | $20.0M |
| FY2018 | $8.5M | $95.1M | $47.4M |
| FY2019 | $27.4M | $75.5M | $44.4M |
| FY2020 | $23.8M | $83.4M | $77.9M |
| FY2021 | $27.4M | $233.1M | $229.8M |
| FY2022 | $30.3M | $181.3M | $144.4M |
| FY2023 | $28.5M | $148.3M | $142.8M |
| FY2024 | $33.6M | $104.6M | $54.5M |
| FY2025 | $27.8M | $72.1M | $70.0M |
When you combine ignorance and leverage, you get some pretty interesting results.